Barbara Pizzo

2.1k total citations · 1 hit paper
37 papers, 1.7k citations indexed

About

Barbara Pizzo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Barbara Pizzo has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Barbara Pizzo's work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (5 papers) and Cancer Treatment and Pharmacology (4 papers). Barbara Pizzo is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (5 papers) and Cancer Treatment and Pharmacology (4 papers). Barbara Pizzo collaborates with scholars based in United States, Italy and Germany. Barbara Pizzo's co-authors include Mark G. Kris, Lee M. Krug, Vincent A. Miller, Leslie B. Tyson, Jorge Gómez, Robert T. Heelan, Christopher G. Azzoli, Naiyer A. Rizvi, Ennapadam Venkatraman and William Pao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Barbara Pizzo

35 papers receiving 1.7k citations

Hit Papers

Bronchioloalveolar Pathologic Subtype and Smoking History... 2004 2026 2011 2018 2004 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer
    2004 628 citations Vincent A. Miller, Mark G. Kris et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Pizzo United States 18 975 947 484 164 120 37 1.7k
Chao‐Hua Chiu Taiwan 25 1.3k 1.4× 1.5k 1.6× 486 1.0× 418 2.5× 148 1.2× 96 2.2k
Shun‐ichi Isa Japan 17 821 0.8× 879 0.9× 247 0.5× 262 1.6× 61 0.5× 43 1.3k
Fábio Franke United States 19 1.3k 1.4× 1.4k 1.5× 558 1.2× 535 3.3× 72 0.6× 54 2.0k
Carrie B. Lee United States 24 759 0.8× 826 0.9× 401 0.8× 201 1.2× 56 0.5× 57 1.7k
Ilaria Conti Italy 19 976 1.0× 786 0.8× 424 0.9× 179 1.1× 51 0.4× 47 1.9k
Vikram K. Chand United States 16 1.2k 1.2× 984 1.0× 387 0.8× 304 1.9× 27 0.2× 68 1.8k
Akihiro Bessho Japan 20 816 0.8× 944 1.0× 319 0.7× 166 1.0× 79 0.7× 92 1.4k
Eckart Laack Germany 23 2.0k 2.1× 2.2k 2.4× 619 1.3× 408 2.5× 86 0.7× 61 3.0k
Meilin Liao China 19 1.3k 1.4× 1.6k 1.7× 571 1.2× 580 3.5× 65 0.5× 45 2.1k
Birthe Lund Denmark 22 1.1k 1.1× 548 0.6× 640 1.3× 145 0.9× 119 1.0× 73 2.3k

Countries citing papers authored by Barbara Pizzo

Since Specialization
Citations

This map shows the geographic impact of Barbara Pizzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Pizzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Pizzo more than expected).

Fields of papers citing papers by Barbara Pizzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Pizzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Pizzo. The network helps show where Barbara Pizzo may publish in the future.

Co-authorship network of co-authors of Barbara Pizzo

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Pizzo. A scholar is included among the top collaborators of Barbara Pizzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Pizzo. Barbara Pizzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pizzo, Barbara, et al.. (2021). The Political Economy of a Collusive Urban Regime: Making Sense of Urban Development Projects in Rome. SHILAP Revista de lepidopterología. 14(2). 806–828. 1 indexed citations
2.
Margalit, Talia, et al.. (2020). TIMES OF CRISIS: NEW PLANNING POLICIES AND THEIR IMPACT ON INEQUALITIES AND THE ENVIRONMENT IN ISRAEL. Università degli Studi di Napoli Federico II. 20(1). 15–23. 1 indexed citations
3.
Falco, Enzo, et al.. (2019). Institutional fragmentation in megaprojects: Lessons from the Metro C project in Rome. Institutional Research Information System (Università degli Studi di Trento). 1 indexed citations
4.
Ramezani, Samira, Barbara Pizzo, & Elizabeth Deakin. (2018). Determinants of sustainable mode choice in different socio-cultural contexts: A comparison of Rome and San Francisco. International Journal of Sustainable Transportation. 12(9). 648–664. 16 indexed citations
5.
Pizzo, Barbara, et al.. (2016). Riscoprire progettualità e risorse locali. TERRITORIO. 85–92.
6.
Pizzo, Barbara, et al.. (2013). Earthquakes, public spaces and (the social construction of) environmental disasters. The role of public space for risk mitigation and urban redevelopment and the role of environmental disasters for re-assessing the ‘space of the Public'. SHILAP Revista de lepidopterología. 3 indexed citations
7.
Pizzo, Barbara, et al.. (2013). Environmental risk prevention, post-seismic interventions and the reconstruction of the public space as a planning challenge. An introduction.. SHILAP Revista de lepidopterología. 3 indexed citations
8.
Azzoli, Christopher G., Lee M. Krug, Vincent A. Miller, et al.. (2007). A Phase II Tolerability Study of Cisplatin Plus Docetaxel as Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 2(7). 638–644. 11 indexed citations
9.
Milton, Daniel T., Gregory J. Riely, Christopher G. Azzoli, et al.. (2007). Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall‐cell lung cancer. Cancer. 110(3). 599–605. 81 indexed citations
10.
Azzoli, Christopher G., Lee M. Krug, Jorge Gómez, et al.. (2007). A Phase 1 Study of Pralatrexate in Combination with Paclitaxel or Docetaxel in Patients with Advanced Solid Tumors. Clinical Cancer Research. 13(9). 2692–2698. 25 indexed citations
11.
Krug, Lee M., John P. Crapanzano, Christopher G. Azzoli, et al.. (2005). Imatinib mesylate lacks activity in small cell lung carcinoma expressing c‐kit protein. Cancer. 103(10). 2128–2131. 117 indexed citations
12.
13.
Pizzo, Barbara. (2004). New Directions in Oncology Nursing Care: Focus on Gefitinib in Patients With Lung Cancer. Clinical journal of oncology nursing. 8(4). 385–392. 2 indexed citations
14.
Kris, Mark G., Alan Sandler, Virginia L. Miller, et al.. (2004). Cigarette smoking history predicts sensitivity to erlotinib: Results of a phase II trial in patients with bronchioloalveolar carcinoma (BAC). Journal of Clinical Oncology. 22(14_suppl). 7062–7062. 16 indexed citations
15.
Kris, Mark G., Alan Sandler, V.A. Miller, et al.. (2004). Cigarette smoking history predicts sensitivity to erlotinib: Results of a phase II trial in patients with bronchioloalveolar carcinoma (BAC). Journal of Clinical Oncology. 22(14_suppl). 7062–7062. 62 indexed citations
16.
17.
Miller, Vincent A., Kenneth Ng, Lee M. Krug, et al.. (2000). Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma. Cancer. 88(5). 1045–1050. 11 indexed citations
18.
19.
Miller, V. A., Kenneth Ng, Stefan C. Grant, et al.. (1997). Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer. Annals of Oncology. 8(12). 1269–1271. 48 indexed citations
20.
Baltzer, Lorraine, et al.. (1984). Bone Marrow Transplantation. AJN American Journal of Nursing. 84(6). 764–764. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chao‐Hua Chiu Breakdown of academic impact, for papers by Shun‐ichi Isa Breakdown of academic impact, for papers by Fábio Franke Breakdown of academic impact, for papers by Carrie B. Lee Breakdown of academic impact, for papers by Ilaria Conti Breakdown of academic impact, for papers by Vikram K. Chand Breakdown of academic impact, for papers by Akihiro Bessho Breakdown of academic impact, for papers by Eckart Laack Breakdown of academic impact, for papers by Meilin Liao Breakdown of academic impact, for papers by Birthe Lund
Rankless by CCL
2026